Ustekinumab for the treatment of psoriasis: a well-established therapy primed for resurgence
{{output}}
Introduction: Ustekinumab has been an approved biologic therapy for moderate-to-severe psoriasis for over 16 years. With the emergence of newer IL-17 and IL-23 inhibitors, its use was largely supplanted by these more effective tr... ...
